coxtral 100mg tableta
zentiva, k.s., praha array - 8782 nimesulid - tableta - 100mg - nimesulid
coxtral
zentiva k.s., Česká republika - nimesulid - 29 - antirheumatica, antiphlogistica, antiuratica
allayex
zentiva k.s. - nimesulidas - tabletės - 100 mg - nimesulide
allayex 100 mg tabletes
zentiva, k.s., czech republic - nimesulīds - tablete - 100 mg
north american coral snake antivenin (equine) (coral snake (micrurus fulvius) immune globulin antivenin- equine injection, powde
wyeth pharmaceuticals llc, a subsidiary of pfizer inc. - coral snake (micrurus fulvius) immune globulin antivenin (equine) (unii: y605xbm2gl) (coral snake (micrurus fulvius) immune globulin antivenin (equine) - unii:y605xbm2gl) - coral snake (micrurus fulvius) immune globulin antivenin (equine) 250 [arb'u] in 10 ml - north american coral snake antivenin (equine) is indicated only for the treatment of envenomation caused by bites of north american coral snakes - micrurus (including the eastern and texas varieties). risk summary there are no available human data that establish developmental toxicity related to the use of north american coral snake antivenin (equine). there are no available animal data informing the north american coral snake antivenin (equine)-associated risk. north american coral snake antivenin (equine) should be given to a pregnant woman only if clearly required. in the us general population, the background risk of major birth defects is 2–4% and of miscarriage is 15–20% in clinically recognized pregnancies. risk summary lactation studies have not been conducted with north american coral snake antivenin (equine). it is not known whether north american coral snake antivenin (equine) is excreted in human milk. north american coral snake antivenin (equine) should be administered to lactating women only if
corallium rubrum d6
staufen-pharma gmbh & co.kg (3090647) - corallium rubrum (pot.-angaben) - flüssige verdünnung zur injektion - teil 1 - flüssige verdünnung zur injektion; corallium rubrum (pot.-angaben) (05238) 1 milliliter
corallium rubrum d6 / stibium d6 aa
weleda a.g. schwäbisch gmünd, - zweigniederlassung der weleda a.g. arlesheim/schweiz - (3003306) - corallium rubrum (pot.-angaben); stibium metallicum (pot.-angaben) - flüssige verdünnung zur injektion - teil 1 - flüssige verdünnung zur injektion; corallium rubrum (pot.-angaben) (05238) 500 milligramm; stibium metallicum (pot.-angaben) (18449) 500 milligramm
corallium rubrum d6/ stibium d6 aa
weleda a.g. schwäbisch gmünd, - zweigniederlassung der weleda a.g. arlesheim/schweiz - (3003306) - corallium rubrum (pot.-angaben); stibium metallicum (pot.-angaben) - mischung aus verreibungen - teil 1 - mischung aus verreibungen; corallium rubrum (pot.-angaben) (05238) 5 gramm; stibium metallicum (pot.-angaben) (18449) 5 gramm
bronchorectine au citral nourrissons, suppositoire
laboratoires mayoly spindler - citral - suppositoire - 2,0 mg - composition pour un suppositoire > citral : 2,0 mg > terpinol : 10,0 mg > pin (huile essentielle de) : 10,0 mg > serpolet (huile essentielle de) : 5,0 mg - a visee antiseptique.
bronchorectine au citral adultes, suppositoire
laboratoires mayoly spindler - citral 0; gaïacol 0; terpinol 0; pin sylvestre (essence de) 0; serpolet (huile essentielle de) 0 - suppositoire - 0,005 g - pour un suppositoire > citral 0,005 g > gaïacol 0,050 g > terpinol 0,030 g > pin sylvestre (essence de 0,030 g > serpolet (huile essentielle de 0,020 g - a visee antiseptique - ce médicament est préconisé au cours des affections bronchiques aigües bénignes chez l'adulte.